Clear Proof Acne System pairs salicylic acid with benzoyl peroxide in a multi-step OTC regimen
DailyMed’s label for CLEAR PROOF ACNE SYSTEM places two familiar acne actives into a single over-the-counter kit: salicylic acid 2% in the cleansing gel and blemish control toner, and benzoyl peroxide 5% in the acne treatment gel. The kit also includes an oil-free moisturizer for acne-prone skin, creating a bundled routine aimed at blackheads, inflammatory pimples, and the skin-barrier injury that often follows overly aggressive acne care.
The label is straightforward about the therapeutic intent. Salicylic acid is identified as an acne medication used for the management of acne, with language specifying reduction in blackheads and acne pimples and prevention of new lesions. Benzoyl peroxide is positioned similarly, with a stronger emphasis on drying up acne pimples and limiting new breakouts. In practice, the combination reflects two different points in acne pathobiology: salicylic acid helps loosen keratinous plugs within the follicle, while benzoyl peroxide exerts antibacterial and comedolytic pressure on the acne unit. When used together, they can hit both clogged pores and the bacterial-inflammation cycle that drives visible flares.
The label leans hard on irritation control and careful sequencing
A recurring theme across the instructions is restraint. The directions advise cleansing the skin thoroughly before applying the product, covering the affected area with a thin layer, and starting with one application daily before increasing to two or three times daily if needed or as directed by a doctor. That escalation schedule is a practical response to a predictable problem: both salicylic acid and benzoyl peroxide can disrupt the stratum corneum, strip surface lipids, and trigger dryness, peeling, burning, or erythema. In acne care, treatment failure and treatment intolerance often begin at the same point—patients overuse a topical, the barrier breaks down, and adherence collapses.
One sentence on the label captures the central safety issue: skin irritation and dryness are more likely when another topical acne medication is used at the same time. The warning is repeated across the salicylic acid products and the benzoyl peroxide gel, and it is not a trivial caution. Layering multiple keratolytic or oxidizing agents can push already inflamed skin beyond tolerance, especially in patients with sensitive skin, post-inflammatory erythema, or concurrent use of scrubs, retinoids, or alcohol-heavy skin care. If bothersome dryness or peeling occurs, the label directs users to reduce frequency to once a day or every other day, a reminder that acne control depends as much on preserving barrier function as on suppressing lesions.
Benzoyl peroxide adds efficacy, but the safety profile is more demanding
The benzoyl peroxide 5% gel carries the most detailed warning language in the kit. It should not be used in people with very sensitive skin or in those who are sensitive to benzoyl peroxide. During use, the label advises avoiding unnecessary sun exposure and using sunscreen, steering clear of the eyes, lips, and mouth, and protecting hair and dyed fabrics because bleaching can occur. The practical implications are immediate: this is an active oxidizing agent with clear contact and cosmetic consequences, and those effects can matter just as much to patients as lesion counts.
Severe irritation is the threshold for stopping and seeking medical review. The label lists redness, burning, itching, peeling, and possible swelling as expected irritation patterns, with the option to reduce frequency or concentration if symptoms are milder. Those instructions matter because benzoyl peroxide is effective precisely because it is active at the skin surface, where acne begins. Its potency can become a liability if patients chase rapid results by applying too much, too often, or in combination with other irritating products.
Moisturizer inclusion signals a barrier-first acne strategy
The kit’s oil-free moisturizer for acne-prone skin is more than a cosmetic add-on. Its ingredient list includes glycerin, niacinamide, dimethicone, betaine, and multiple emollient and humectant components, all of which are consistent with barrier support and hydration without heavy occlusion. For patients using benzoyl peroxide or salicylic acid, a non-comedogenic moisturizer can reduce the dryness spiral that often leads to nonadherence. Niacinamide, in particular, is often used in acne-prone skin care because it is generally compatible with sensitive skin and can help support barrier integrity while avoiding the greasy feel many patients reject.
This detail gives the kit its real-world logic. Acne therapy fails when a regimen is biologically sound but operationally unpleasant. A cleanser, toner, active treatment gel, and moisturizer arranged in one package can simplify use, though the label still requires thoughtful dose ramping and attention to skin response.
Packaging, storage, and product classification are clearly defined
The label classifies the kit as a HUMAN OTC DRUG and lists no DEA schedule. The package is identified under NDC 51531-8977-0, with the carton containing four parts: the acne treatment gel, the clarifying cleansing gel, the blemish control toner, and the moisturizer. The kit was marked with a marketing start date of August 15, 2013, and the label information was updated October 13, 2026.
Storage instructions are conventional but important: keep the product at 59°F to 86°F, and note the expiration date on the tube crimp. For a topical acne kit, stability is not an abstract manufacturing footnote. Temperature extremes can alter texture, spreading, and user experience, all of which influence whether the regimen is used correctly and consistently.
What the label makes clear at the bedside
This is a topical acne system built around a familiar dermatologic tradeoff: enough activity to suppress comedones and pimples, but not so much irritation that the patient abandons therapy. Salicylic acid opens clogged follicles. Benzoyl peroxide attacks the acne lesion environment more aggressively. The moisturizer tries to preserve skin tolerance long enough for the actives to work.
The key limitation is built into the directions themselves. The regimen depends on gradual titration, strict avoidance of contact with the eyes and mucous membranes, and a willingness to back off if dryness or peeling becomes bothersome. For patients with highly sensitive skin, concurrent topical acne products may be hard to tolerate, and the label makes that concern explicit. Any use beyond the package instructions would require clinical judgment, especially if acne is severe, widespread, or accompanied by scarring, inflammatory nodules, or significant psychosocial distress.